Cargando…
Evidence for new targets and synergistic effect of metronomic celecoxib/fluvastatin combination in pilocytic astrocytoma
BACKGROUND: Pilocytic astrocytomas occur predominantly in childhood. In contrast to the posterior fossa location, hypothalamo-chiasmatic pilocytic astrocytomas display a worse prognosis often leading to multiple surgical procedures and/or several lines of chemotherapy and radiotherapy to achieve lon...
Autores principales: | Mercurio, Sandy, Padovani, Laetitia, Colin, Carole, Carré, Manon, Tchoghandjian, Aurélie, Scavarda, Didier, Lambert, Sally, Baeza-Kallee, Nathalie, Fernandez, Carla, Chappé, Céline, André, Nicolas, Figarella-Branger, Dominique |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3893468/ https://www.ncbi.nlm.nih.gov/pubmed/24252689 http://dx.doi.org/10.1186/2051-5960-1-17 |
Ejemplares similares
-
Proscillaridin A is cytotoxic for glioblastoma cell lines and controls tumor xenograft growth in vivo
por: Denicolaï, Emilie, et al.
Publicado: (2014) -
A2B5 Expression in Central Nervous System and Gliomas
por: Figarella-Branger, Dominique, et al.
Publicado: (2022) -
Glycolipids Recognized by A2B5 Antibody Promote Proliferation, Migration, and Clonogenicity in Glioblastoma Cells
por: Baeza-Kallee, Nathalie, et al.
Publicado: (2019) -
Proscillaridin A exerts anti-tumor effects through GSK3β activation and alteration of microtubule dynamics in glioblastoma
por: Berges, Raphael, et al.
Publicado: (2018) -
Can metronomic maintenance with weekly vinblastine prevent early relapse/progression after bevacizumab–irinotecan in children with low‐grade glioma?
por: Heng, Marie Amélie, et al.
Publicado: (2016)